PSA testing guidelines approved
New guidelines developed to resolve the controversy surrounding prostate specific antigen (PSA) blood testing have been approved by the NHMRC. Developed by Prostate Cancer Foundation of Australia (PCFA) and Cancer Council Australia, the guidelines recommend that men considering PSA testing are given the opportunity to discuss the benefits and harms of testing before deciding whether to be tested. For men who decide to be tested, guidance is given on issues such as age to start, frequency of and when to stop testing. Read PSA Testing and Early Management of Test-Detected Prostate Cancer: Guidelines for Health Professionals on PCFA's website (www.pcfa.org.au).
Detailed information on the current status of shortages of the most commonly used allergen extracts in Australia, which are imported from French company Stallergenes, is available on the Australasian Society of Clinical Immunology and Allergy's (ASCIA's) website (www.allergy.org.au). According to ASCIA, the allergen shortages are extending into 2016, and although other brands of allergen extracts are available for importation and use, these are not currently interchangeable with Stallergenes' products.